Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company developing novel immunotherapies against cancer, announces its fourth quarter 2024 results ...
Aaron Patrick, Head of Accounts at Boffix and an official Intuit QuickBooks Certified Trainer shares 10 essential QuickBooks tips to help you save time ...
Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration GAAP1 operating ...